NDC 55566-2300

DDAVP

Desmopressin Acetate

DDAVP is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Ferring Pharmaceuticals Inc.. The primary component is Desmopressin Acetate.

Product ID55566-2300_740b6907-082b-9e0e-e053-2991aa0a38f0
NDC55566-2300
Product TypeHuman Prescription Drug
Proprietary NameDDAVP
Generic NameDesmopressin Acetate
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date1984-03-30
Marketing CategoryNDA / NDA
Application NumberNDA018938
Labeler NameFerring Pharmaceuticals Inc.
Substance NameDESMOPRESSIN ACETATE
Active Ingredient Strength4 ug/mL
Pharm ClassesFactor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 55566-2300-0

1 VIAL, MULTI-DOSE in 1 CARTON (55566-2300-0) > 10 mL in 1 VIAL, MULTI-DOSE
Marketing Start Date1984-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55566-2300-0 [55566230000]

DDAVP INJECTION
Marketing CategoryNDA
Application NumberNDA018938
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1984-03-30

Drug Details

Active Ingredients

IngredientStrength
DESMOPRESSIN ACETATE4 ug/mL

OpenFDA Data

SPL SET ID:651f6fee-a2c7-431b-8d5d-58b156c72244
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1723232
  • 1723234
  • 849501
  • 849503

    • Pharmacological Class

    • Factor VIII Activator [EPC]
    • Increased Coagulation Factor VIII Activity [PE]
    • Increased Coagulation Factor VIII Concentration [PE]
    • Vasopressin Analog [EPC]
    • Vasopressins [CS]

    NDC Crossover Matching brand name "DDAVP" or generic name "Desmopressin Acetate"

    NDCBrand NameGeneric Name
    55566-2400DDAVPDDAVP
    55566-2500DDAVPDDAVP
    55566-2600DDAVPDDAVP
    55566-2200DDAVPDDAVP
    55566-2300DDAVPDDAVP
    55566-2700DDAVPDDAVP
    0115-1646Desmopressin AcetateDesmopressin Acetate
    0115-1647Desmopressin AcetateDesmopressin Acetate
    0409-2265Desmopressin AcetateDesmopressin Acetate
    0517-4310Desmopressin AcetateDesmopressin Acetate
    0591-2464Desmopressin AcetateDesmopressin Acetate
    0591-2465Desmopressin AcetateDesmopressin Acetate
    0615-7549Desmopressin AcetateDesmopressin Acetate
    0703-5051Desmopressin acetateDesmopressin acetate
    0703-5054Desmopressin acetateDesmopressin acetate
    10702-169Desmopressin AcetateDesmopressin Acetate
    10702-170Desmopressin AcetateDesmopressin Acetate
    16714-015Desmopressin AcetateDesmopressin Acetate
    16714-883Desmopressin AcetateDesmopressin Acetate
    16714-884Desmopressin AcetateDesmopressin Acetate
    23155-489Desmopressin AcetateDesmopressin Acetate
    23155-490Desmopressin AcetateDesmopressin Acetate
    24208-342Desmopressin AcetateDesmopressin Acetate
    25021-460desmopressin acetatedesmopressin acetate
    25021-461desmopressin acetatedesmopressin acetate
    43598-053Desmopressin AcetateDesmopressin Acetate
    43598-931DESMOPRESSIN ACETATEDESMOPRESSIN ACETATE
    47335-788Desmopressin AcetateDesmopressin Acetate
    50268-220Desmopressin AcetateDesmopressin Acetate
    50268-221Desmopressin AcetateDesmopressin Acetate
    54436-325NOCDURNADESMOPRESSIN ACETATE
    0053-6871StimateDESMOPRESSIN ACETATE

    Trademark Results [DDAVP]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DDAVP
    DDAVP
    74734670 1997079 Live/Registered
    AVENTISUB LLC
    1995-09-27
    DDAVP
    DDAVP
    73399946 1386510 Dead/Cancelled
    ARMOUR PHARMACEUTICAL COMPANY
    1982-10-12
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.